EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model

Langlang Tang, Kaiqian Que, Yanfen Lan, Yimin Li, Bin Wang, Zhuting Fang

European Journal of Radiology · 2026

DOI: 10.1016/j.ejrad.2026.112705 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Radiology, 2026. Verfasst von Langlang Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key La…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, Chemoembolization, Therapeutic. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop and validate a prognostic model integrating pretreatment MRI features and clinical characteristics for hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) combined targeted immunotherapy (TII). A weighted scoring system was developed to improve the model's clinical utility. METHODS: We retrospectively recruited 141 patients with HCC from multiple centers, with 98 in the training cohort and 43 in the validation cohort. The independent predictors were identified using univariate and multivariate Cox regression analyses and developed a clinical nomogram. We constructed an 10-point weighted scoring system incorporating imaging features. Model performance was evaluated using AUC, decision curve analysis (DCA), and calibration curves assessed via bootstrapping. RESULTS: Logistic regression identified four risk factors for objective response (OR): irregular tumor border, absent of Intratumoral artery, albumin-bilirubin (ALBI) score ≥ -2.352, number ≥ 2, and tumor histopathological enhancement (THPE). The AUC was 0.804 in the training cohort and 0.580 in the validation cohort. The Akaike Information Criterion (AIC) for the scoring model was lower than the other model for predicting OR, progression-free survival (PFS), and overall survival (OS). Patients with a scoring model value > 5.5 points were classified as high-risk. The Kaplan-Meier (K-M) curves of the scoring model showed the better discriminative ability for PFS and OS. CONCLUSION: The functional imaging-liver function synergy model demonstrates superior prognostic accuracy over conventional tumor burden parameters in hepatocellular carcinoma patients receiving quadruple therapy. Furthermore, the derived 10-point scoring system enables clinically actionable risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMagnetic Resonance ImagingChemoembolization, TherapeuticHumansFemaleMalePrognosisMiddle AgedTreatment OutcomeReproducibility of ResultsRetrospective StudiesAgedLiver Function TestsCombined Modality TherapySensitivity and SpecificityRisk FactorsInfusions, Intra-Arterial

Stichwörter der Autor:innen

ALBI gradeHepatocellular carcinomaMRIPredictionRisk stratification

Autor:innen und Institutionen

  • Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou 350014, China; Department of Rad…
  • Department of Radiation Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan 364000, China.
  • Department of Radiology, Zhangzhou affiliated Hospital of Fujian Medical University, Fujian, Fuzhou 363000, China.
  • Department of Pathology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan 364000, China.
  • Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou 350014, China. Electronic addres…

Förderung

  • National Key Research and Development Program of China
  • Fujian Provincial Health Technology Project

Zitieren

APA

Tang, L., Que, K., Lan, Y., Li, Y., Wang, B., & Fang, Z. (2026). Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2026.112705

Vancouver

Tang L, Que K, Lan Y, Li Y, Wang B, Fang Z. Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model. European Journal of Radiology. 2026. doi:10.1016/j.ejrad.2026.112705

BibTeX
@article{Tang2026,
  author = {Tang, Langlang and Que, Kaiqian and Lan, Yanfen and Li, Yimin and Wang, Bin and Fang, Zhuting},
  title = {Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model},
  journal = {European Journal of Radiology},
  year = {2026},
  doi = {10.1016/j.ejrad.2026.112705}
}
Kostenlos starten →